Valstar (valrubicin) — ENDO PHARM INC.

Malignant tumor of urinary bladder
40 mg/mL intravesical solution
Dosage information is not available

40 mg/mL intravesical solution
Dosage information is not available

Severe Warnings
Bladder hyperactivity
Bladder surgery
Pregnancy
Contraindicated
Lactating mother
Rupture of bladder
Small capacity bladder
Urinary tract infection
Moderate Warnings
None
Less Frequent
Severe
Chest pain
Skin rash
Vasodilation of blood vessels

Less Severe
Abdominal pain with cramps
Back pain
Bladder pain
Diarrhea
Dizziness
Fever
Flatulence
General weakness
Headache disorder
Malaise
Nausea
Nocturia
Pelvic pain
Urinary burning sensation
Vomiting
More Frequent
Severe
None

Less Severe
Bladder irritability
Dysuria
Hematuria
Increased urinary frequency
Urinary incontinence
Urinary tract infection
Urine discoloration
Rare / Very Rare
Severe
Hyperglycemia
Peripheral edema
Pneumonia

Less Severe
Dysgeusia
Myalgias
Pruritus of skin
Tenesmus
More information
No precaution information has been provided for this patient type.
Valrubicin
Severity Level: D
Additional Notes: Insuff human data; based on drug pharmacology dev tox may occur

More information
Contraindicated
Valrubicin
GeneralExcretion PotentialEffect on InfantNotes
Drug should not be given to breast feeding mothersUnknownNot known; no or inclusive dataHighly lipophilic; possible severe adverse effects.

Precaution Exists
None

No Known Risk
None
More information
No precaution information has been provided for this patient type.
Malignant tumor of urinary bladder
C67Malignant neoplasm of bladder
C67.0Malignant neoplasm of trigone of bladder
C67.1Malignant neoplasm of dome of bladder
C67.2Malignant neoplasm of lateral wall of bladder
C67.3Malignant neoplasm of anterior wall of bladder
C67.4Malignant neoplasm of posterior wall of bladder
C67.5Malignant neoplasm of bladder neck
C67.6Malignant neoplasm of ureteric orifice
C67.7Malignant neoplasm of urachus
C67.8Malignant neoplasm of overlapping sites of bladder
C67.9Malignant neoplasm of bladder, unspecified
0-9 A-Z
C67 Malignant neoplasm of bladder
C67.0 Malignant neoplasm of trigone of bladder
C67.1 Malignant neoplasm of dome of bladder
C67.2 Malignant neoplasm of lateral wall of bladder
C67.3 Malignant neoplasm of anterior wall of bladder
C67.4 Malignant neoplasm of posterior wall of bladder
C67.5 Malignant neoplasm of bladder neck
C67.6 Malignant neoplasm of ureteric orifice
C67.7 Malignant neoplasm of urachus
C67.8 Malignant neoplasm of overlapping sites of bladder
C67.9 Malignant neoplasm of bladder, unspecified

Data included with permission and copyrighted by First DataBank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgement of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. Diagnosis codes are provided for reference only. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatement.